Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly C Handy

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biomarkers in Medicine|April 14, 2010
Accelerating Development and Advancing Personalized Therapy (ADAPT) Congress. Washington, DC, USA, 22-25 September 2009Beverly C Handy
Clinical Biochemistry|July 11, 2015
Falsely elevated tacrolimus concentrations on the Dimension XpandQing H Meng, Beverly C Handy, Elizabeth A Wagar
Pathology|March 9, 2019
Biclonal presentation of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemiaWei Wang, Yi Ding, Andrew Campbell, et al.
American Journal of Clinical Pathology|April 22, 2005
Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patientsPei Lin, Suyang Hao, Beverly C Handy, et al.
Archives of Pathology & Laboratory Medicine|March 17, 2018
Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate CancerLiyun Cao, Chi Hyun Lee, Jing Ning, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 12, 2016
Causes and impact of specimen rejection in a clinical chemistry laboratoryLiyun Cao, Meng Chen, Ron A Phipps, et al.
American Journal of Clinical Pathology|March 4, 2005
Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraproteinC Cameron Yin, Pei Lin, Dennis A Carney, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancerUgo De Giorgi, Michal Mego, Eric M Rohren, et al.
Breast Cancer Research and Treatment|December 18, 2012
Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancerWindy Dean-Colomb, Kenneth R Hess, Elliana Young, et al.
Breast Cancer Research : BCR|June 25, 2011
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatmentMario Giuliano, Antonio Giordano, Summer Jackson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biomarkers in Medicine|April 14, 2010
Accelerating Development and Advancing Personalized Therapy (ADAPT) Congress. Washington, DC, USA, 22-25 September 2009Beverly C Handy
Clinical Biochemistry|July 11, 2015
Falsely elevated tacrolimus concentrations on the Dimension XpandQing H Meng, Beverly C Handy, Elizabeth A Wagar
Pathology|March 9, 2019
Biclonal presentation of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemiaWei Wang, Yi Ding, Andrew Campbell, et al.
American Journal of Clinical Pathology|April 22, 2005
Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patientsPei Lin, Suyang Hao, Beverly C Handy, et al.
Archives of Pathology & Laboratory Medicine|March 17, 2018
Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate CancerLiyun Cao, Chi Hyun Lee, Jing Ning, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 12, 2016
Causes and impact of specimen rejection in a clinical chemistry laboratoryLiyun Cao, Meng Chen, Ron A Phipps, et al.
American Journal of Clinical Pathology|March 4, 2005
Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraproteinC Cameron Yin, Pei Lin, Dennis A Carney, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancerUgo De Giorgi, Michal Mego, Eric M Rohren, et al.
Breast Cancer Research and Treatment|December 18, 2012
Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancerWindy Dean-Colomb, Kenneth R Hess, Elliana Young, et al.
Breast Cancer Research : BCR|June 25, 2011
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatmentMario Giuliano, Antonio Giordano, Summer Jackson, et al.
Pageof 2